Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05981911 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

Study acronym: IRIS Skypoint
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 2, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Sep 2025 to Jun 2026
    • Study completion date: Feb 2026 to Dec 2026
    v4
  2. Start date changed from estimate of Dec 30, 2023 to Dec 14, 2023v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 2023 to Dec 30, 2023
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
Trial Details
NCT Number NCT05981911
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov